Tom Sellers steps down as director of OHSU Knight, replaced by Lisa CoussensShivaani Kummar recently named interim CEO April 11, 2025Vol.51 No.14By Paul Goldberg
Trials & Tribulations Genetic counseling can improve genetic screening and accelerate clinical trial success April 11, 2025Vol.51 No.14By Ashley Cannon
FreeObituary Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97An architect of today’s Roswell Park April 11, 2025Vol.51 No.14By Roswell Park Comprehensive Cancer Center
FreeObituary Tomasi revived basic and clinical research at Roswell Park April 11, 2025Vol.51 No.14By Jerome Yates
FreeIn the Archives Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings April 11, 2025Vol.51 No.14
Conversation with The Cancer Letter Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy April 04, 2025Vol.51 No.13By Paul Goldberg
Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDAMeanwhile, NASEM sounds “SOS” for health infrastructure April 04, 2025Vol.51 No.13By Claire Marie Porter, Paul Goldberg and Jacquelyn Cobb
Conversation with The Cancer Letter Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising recordCurrent record: $507,000. Proceeds to go to LLS as NIH funding is slashed April 04, 2025Vol.51 No.13By Jacquelyn Cobb
Guest Editorial Rathmell: We must put the individual at the center of our approach to ending cancer April 04, 2025Vol.51 No.13By W. Kimryn Rathmell
Sponsored How City of Hope is using AI to improve surgical outcomes April 04, 2025Vol.51 No.13By City of Hope
